Online Analyzer Marks Breakthrough in Managing Depression
December 20, 2011 09:41 ET | Families for Depression Awareness
WALTHAM, Mass., Dec. 20, 2011 (GLOBE NEWSWIRE) -- People dealing with depression now have a new and potentially powerful ally: technology. The Depression Wellness Analyzer is a breakthrough online...
PA Consulting Group's "Managing Uncertainty" Survey Provides Lessons for Business Leaders for the Next Emerging Crisis
December 05, 2011 12:44 ET | PA Consulting Group US
NEW YORK, Dec. 5, 2011 (GLOBE NEWSWIRE) -- As the global economy heads back into crisis, business leaders are focusing on what they need to do to succeed in uncertain times. Most companies had the...
Doctor Reveals How to Manage Depression Without Resorting to Prescription Drugs
October 07, 2011 14:47 ET | Author Dr. Gregory Jantz
SEATTLE, WA--(Marketwire - Oct 7, 2011) - In the past, people suffering from depression were often given two choices -- medicate it or deal with it. Dr. Gregory Jantz, a licensed mental...
Neuronetics, Inc. Raises $30 Million in Series E Financing
May 16, 2011 08:30 ET | Neuronetics
MALVERN, PA--(Marketwire - May 16, 2011) - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® System for the treatment of major depression*, announced today...
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting
May 15, 2011 19:00 ET | Neuronetics
HONOLULU, HI--(Marketwire - May 15, 2011) - Results of a Neuronetics-sponsored, multisite observational study of patients with major depressive disorder (MDD) treated with Neuronetics' NeuroStar...
Neuronetics Receives TiE50 Award for Technology Entrepreneurship
May 09, 2011 08:30 ET | Neuronetics
MALVERN, PA--(Marketwire - May 9, 2011) - Neuronetics, Inc., maker of the NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy® System, has been selected by TiE Silicon Valley as a 2011 recipient...
New Data Show No Negative Long-Term Effect in Cognitive Function in Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)
April 14, 2011 13:30 ET | Neuronetics
HONOLULU, HI--(Marketwire - Apr 14, 2011) - In an open-label study of patients with major depressive disorder (MDD) who had not benefitted from prior antidepressant medication and were treated with...
Neuronetics Appoints Vice President of Health Policy and Government Relations
March 02, 2011 08:00 ET | Neuronetics
MALVERN, PA--(Marketwire - March 2, 2011) - Neuronetics, Inc. today announced that Mary Hailey, an industry executive with more than 25 years of experience in designing and implementing healthcare...
NeuroStar TMS Therapy Continues to Grow as a Standard of Care for Patients With Depression
January 10, 2011 13:13 ET | Neuronetics
MALVERN, PA--(Marketwire - January 10, 2011) - Neuronetics, Inc., is pleased to announce that effective January 1, 2011, new Category I CPT® codes are available for billing the medical...
Quietmind Foundation Forms Quietmind Associates
November 08, 2010 13:22 ET | Quietmind Foundation
PLYMOUTH MEETING, PA--(Marketwire - November 8, 2010) -  Marvin H. Berman, PhD, CBT, BCN, a clinician in private practice and founder and president of Quietmind Foundation (QMF), announces the...